Analysis and Understanding of Aptamer and Peptide Molecular Interactions Application to Mucin 1 (Muc1) Aptasensor

被引:0
|
作者
Rhinehardt, Kristen [1 ]
Mohan, Ram [1 ]
Srinivas, Goundla [1 ]
Kelkar, Ajit [1 ]
机构
[1] North Carolina A&T State Univ, Joint Sch Nanosci & Nanoengn, Dept Nanoengn, Greensboro, NC 27411 USA
关键词
Aptamer; Peptide; Molecular Dynamics; Biosensor; AMPEROMETRIC BIOSENSOR; DYNAMICS; SIMULATIONS; PROTEIN;
D O I
暂无
中图分类号
TM [电工技术]; TN [电子技术、通信技术];
学科分类号
0808 ; 0809 ;
摘要
Molecular level interactions and accessibility to binding site play a critical role in efficacy of biosensors. Details on the orientation and location of binding of a biomarker to a bioreceptor can be obtained through computational modeling and analysis. In the present paper, Molecular Dynamics (MD) was used to model the and understand the molecular interaction within a aptamer based sensor using a known peptide-aptamer combination of anti-mucin 1 S2.2 aptamer and MUC1-G (ADPTRPAPG) peptide in a 150mM NaCl solution to mirror SPR aptasensor conditions. The modeling analysis was further extended to understand the influence of other solvent environments. In the solvent environment of 150mM NaCl, MUC1-G binding event was found to occur consistently in the loop region of the aptamer, and showed a key role of arginine residue of the peptide in the aptamer-peptide binding. To further emulate relevant biosensor application characteristics, variation in aptamer and peptide structure as well as solvent conditions were studied and analyzed. These illustrated the sensitivity and selectivity of MUC1-G peptide-aptamer binding. Selective changes in the solvent conditions to reflect a variety of physiological conditions that can be experienced in biosensor applications were modeled through modifications in the peptideaptamer-solvent molecular systems. Results indicate that certain modified solvent conditions did not induce binding, but rather association events. Present results indicate even variations in the solvent conditions for biosensor applications can impact the binding. Insights from modeling and analysisillustrate the selectiveness and sensitivity to solvent environments in the case of Mucin 1, a breast cancer biomarker, which are critical to the development ofreliable and repeatable biosensors.
引用
收藏
页码:297 / 302
页数:6
相关论文
共 50 条
  • [41] MUC1 in carcinoma-host interactions
    Kaori Denda-Nagai
    Tatsuro Irimura
    Glycoconjugate Journal, 2000, 17 : 649 - 658
  • [42] Cytotoxic T lymphocytes from humans with adenocarcinomas stimulated by native MUC1 mucin and a mucin peptide mutated at a glycosylation site
    Wright, SE
    Kilinski, G
    Talib, G
    Lowe, KE
    Burnside, JS
    Wu, JY
    Dolby, N
    Dombrowski, KE
    Lebkowski, JS
    Philip, R
    JOURNAL OF IMMUNOTHERAPY, 2000, 23 (01): : 2 - 10
  • [43] Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas
    Baldus, SE
    Zirbes, TK
    Engel, S
    Hanisch, FG
    Mönig, SP
    Lorenzen, J
    Glossmann, J
    Fromm, S
    Thiele, J
    Pichlmaier, H
    Dienes, HP
    INTERNATIONAL JOURNAL OF CANCER, 1998, 79 (02) : 133 - 138
  • [44] Tumor-associated MUC1 glycopeptide epitopes are not subject to self-tolerance and improve responses to MUC1 peptide epitopes in MUC1 transgenic mice
    Ryan, Sean O.
    Vlad, Anda M.
    Islam, Kazi
    Gariepy, Jean
    Finn, Olivera J.
    BIOLOGICAL CHEMISTRY, 2009, 390 (07) : 611 - 618
  • [45] Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine
    Lakshminarayanan, Vani
    Thompson, Pamela
    Wolfert, Margreet A.
    Buskas, Therese
    Bradley, Judy M.
    Pathangey, Latha B.
    Madsen, Cathy S.
    Cohen, Peter A.
    Gendler, Sandra J.
    Boons, Geert-Jan
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (01) : 261 - 266
  • [46] THE ROLE OF THE CYTOPLASMIC TAIL DOMAIN IN ACTIN INTERACTIONS AND IN THE POLARIZED LOCALIZATION OF A CELL ASSOCIATED MUCIN, MUC1
    PEMBERTON, L
    TAYLORPAPADIMITRIOU, J
    GENDLER, SJ
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 272 - 272
  • [47] Label-free sensing of the binding state of MUC1 peptide and anti-MUC1 aptamer solution in fluidic chip by terahertz spectroscopy
    Zhao, Xiang
    Zhang, Mingkun
    Wei, Dongshan
    Wang, Yunxia
    Yan, Shihan
    Liu, Mengwan
    Yang, Xiang
    Yang, Ke
    Cui, Hong-Liang
    Fu, Weiling
    BIOMEDICAL OPTICS EXPRESS, 2017, 8 (10): : 4427 - 4437
  • [48] Role of endocytosis in the maturation of the membrane-associated mucin MUC1
    Altschuler, Y
    Poland, PA
    Kinlough, CL
    Hughey, RP
    MOLECULAR BIOLOGY OF THE CELL, 1997, 8 : 1745 - 1745
  • [49] Tissue and serum MUC1 mucin detection in breast cancer patients
    Croce, MV
    Isla-Larrain, MT
    Demichelis, SO
    Gori, JR
    Price, MR
    Segal-Eiras, A
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 81 (03) : 195 - 207
  • [50] Dendritic cell vaccine immunotherapy of cancer targeting MUC1 mucin
    Kontani, K
    Taguchi, O
    Ozaki, Y
    Hanaoka, J
    Sawai, S
    Inoue, S
    Abe, H
    Hanasawa, K
    Fujino, S
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2003, 12 (04) : 493 - 502